神经营养性角膜病(NK)是一种相对少见的退行性角膜疾病,随着时间的推移,可造成不同程度的眼表损害,导致角膜溃疡、穿孔甚至致盲。改善眼表损害的最佳时机在NK的早期阶段,而早期NK患者的典型症状较少,导致其诊断往往被延误。2021年《BMC Ophthalmology》于21卷第1期发布了《神经营养性角膜病的识别、诊断和治疗的专家共识》。本文通过对该共识中NK筛查时机以及最佳的诊断和治疗方案进行解读,以期进一步提高眼科医生对筛查和治疗NK的认识,并优化NK诊断和治疗方案的管理规范。
Neurotrophic keratopathy (NK) is a relatively rare degenerative corneal disease.Over time, it can cause varying degrees of ocular surface damage, leading to corneal ulcers, perforations and even blindness.The best opportunity to reverse ocular surface damage is in the earliest stage of NK.However, patients experience few typical symptoms and diagnosis is often delayed.In 2021, BMC Ophthalmology published the Expert Consensus on the Identification, Diagnosis and Treatment of Neurotrophic Keratopathy in Volume 21.Through the interpretation of the consensus, this paper hopes to further improve ophthalmologists' understanding of the screening and treatment of NK, and optimize the management norms of NK diagnosis and treatment.
郭楚祎,石文卿,邵毅. 《神经营养性角膜病的识别、诊断和治疗的专家共识》解读[J]. 中华实验眼科杂志,2023,41(03):282-284.
DOI:10.3760/cma.j.cn115989-20220829-00399版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。